A Putative Oral Vaccine based on Live Lactococci Expressing the Surface Glycoproteins Respiratory Syncytial Virus.
Although 50 years have elapsed since the discovery of respiratory syncytial virus (RSV), it remains the primary cause of lower respiratory tract disease in children worldwide without a licensed vaccine which is of utmost priority. On the other hand, bacterial surface display has, in the last two dec...
Saved in:
Main Author: | Lim, Erin Swee Hua |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/22121/1/IB%202010%207R.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a Novel Oral Vaccine Against Human Resipratory Syncytial Virus
by: Jalilian, Farid Azizi
Published: (2011) -
Development of DNA and Oral Vaccines Against Chicken Anemia Virus
by: Moeini, Hassan
Published: (2010) -
Development of Salmonella-based DNA vaccine against respiratory syncytial virus.
by: Suhaimi, Siti Syazani
Published: (2011) -
Production and purification of nipah virus glycoprotein in Spodoptera frugiperda 9 (J.E. Smith) insect cell
by: Sunhare, Raksha
Published: (2013) -
Production, characterization and scaling up of monoclonal antibodies against neuraminidase glycoprotein of avian influenza virus subtype H9N2
by: Abdelaziz Fadul, Sana Awad
Published: (2011)